Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors

Clinical trial NCT07257484 · RECRUITING

Trial details

NCT number: NCT07257484
Sponsor: Weill Medical College of Cornell University
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Obesity (Disorder)Breast Cancer

Start date: 2026-06-08
Primary completion: 2027-12-03
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.